HTFL · Insider trading · 13F holders · Congress trades
Heartflow, Inc. (HTFL)
Who is buying and selling HTFL: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 15
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $15.5M
- Congress trades, 12 months
- 0
HTFL at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 HTFL insiders filed 13 sales worth $15.5M on SEC Form 4, and no open-market purchases; 13 of the sales were pre-planned under Rule 10b5-1.
- 15 13F filers hold HTFL among their 50 largest positions, worth $434.2M combined. The biggest bets by portfolio weight are Bain Capital Life Sciences Investors, LLC (14.7%), 12 West Capital Management LP (5.0%) and Catalio Capital Management, LP (3.2%). In their latest 13Fs, 0 managers opened a new position and 5 added to one.
- No member of Congress has disclosed a trade in HTFL.
- HTFL last closed at $60.53 on Oct 29, 2026.
HTFL insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 HTFL insiders filed 13 sales worth $15.5M on SEC Form 4, and no open-market purchases; 13 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Rogers Campbell | Chief Medical Officer | Sale10b5-1 | 23,933 | $55.01 | $1.3M | SEC |
| Oct 14, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sale10b5-1 | 38,900 | $49.57 | $1.9M | SEC |
| Sep 21, 2026 | Rogers Campbell | Chief Medical Officer | Sale10b5-1 | 19,682 | $50.15 | $987K | SEC |
| Sep 18, 2026 | Verghese Vikram | Chief Financial Officer | Sale10b5-1 | 24,345 | $50.55 | $1.2M | SEC |
| Sep 15, 2026 | Verghese Vikram | Chief Financial Officer | Sale10b5-1 | 34,975 | $50.08 | $1.8M | SEC |
| Sep 14, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sale10b5-1 | 38,900 | $46.78 | $1.8M | SEC |
| Sep 10, 2026 | Verghese Vikram | Chief Financial Officer | Sale10b5-1 | 6,640 | $50.03 | $332K | SEC |
| Sep 4, 2026 | Verghese Vikram | Chief Financial Officer | Sale10b5-1 | 33,416 | $49.85 | $1.7M | SEC |
| Aug 25, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sale10b5-1 | 27,230 | $50.00 | $1.4M | SEC |
| Aug 20, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sale10b5-1 | 32,676 | $45.00 | $1.5M | SEC |
| Aug 19, 2026 | Rogers Campbell | Chief Medical Officer | Sale10b5-1 | 9,219 | $41.23 | $380K | SEC |
| Aug 18, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sale10b5-1 | 15,560 | $39.06 | $608K | SEC |
| Aug 12, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sale10b5-1 | 22,562 | $28.31 | $639K | SEC |
Who owns HTFL? Hedge funds and superinvestors
15 13F filers hold HTFL among their 50 largest positions, worth $434.2M combined. The biggest bets by portfolio weight are Bain Capital Life Sciences Investors, LLC (14.7%), 12 West Capital Management LP (5.0%) and Catalio Capital Management, LP (3.2%). In their latest 13Fs, 0 managers opened a new position and 5 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLCAsset manager | 14.7% | $247.9M | 8,448,158 | -19.1% shares | Q2 2026 |
| Summit Partners Public Asset Management, LLCHedge fund | 1.3% | $49.7M | 1,694,651 | +90.0% shares | Q2 2026 |
| 12 West Capital Management LPHedge fund | 5.0% | $26.5M | 902,500 | +41.0% shares | Q2 2026 |
| Next Century Growth Investors LLCInstitutional asset manager | 1.0% | $19.7M | 671,404 | +2.8% shares | Q2 2026 |
| NZS Capital, LLCHedge fund | 0.5% | $19.2M | 656,014 | — | Q2 2026 |
| XXEC, Inc.Wealth manager | 2.4% | $18.4M | 599,194 | +115.0% shares | Q2 2026 |
| Catalio Capital Management, LPHedge fund | 3.2% | $17.1M | 583,055 | +44.5% shares | Q2 2026 |
| Rock Springs Capital Management LPHedge fund | 0.8% | $16.8M | 573,500 | +0.2% shares | Q2 2026 |
| Lisanti Capital Growth, LLCInstitutional asset manager | 1.2% | $5.6M | 189,675 | — | Q2 2026 |
| Brown Capital Management LLCMutual fund manager | 1.0% | $5.0M | 101,190 | +23.3% shares | Q3 2026 |
| Intrepid Family Office LLCFamily office | 3.0% | $3.2M | 110,000 | +0.0% shares | Q2 2026 |
| TFC Financial Management, Inc.Wealth manager | 0.3% | $2.8M | 55,598 | +0.0% shares | Q3 2026 |
| AlpInvest Partners B.V.Hedge fund | 1.8% | $1.1M | 36,504 | -3.1% shares | Q2 2026 |
| Bcwm, LLCWealth manager | 0.3% | $935K | 31,878 | +1.8% shares | Q2 2026 |
| Brandywine Managers, LLCHedge fund | 0.1% | $294K | 10,024 | -40.2% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 2, Q2 2026: 13). Screen HTFL in the grand portfolio →
HTFL stock trades by members of Congress
No member of Congress has disclosed a trade in HTFL.
Analysis mentioning HTFL
Posts from the blog that cover Heartflow, Inc., newest first.
HTFL questions and answers
Are insiders buying HTFL stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 HTFL insiders filed 13 sales worth $15.5M on SEC Form 4, and no open-market purchases; 13 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own HTFL?
15 13F filers hold HTFL among their 50 largest positions, worth $434.2M combined. The biggest bets by portfolio weight are Bain Capital Life Sciences Investors, LLC (14.7%), 12 West Capital Management LP (5.0%) and Catalio Capital Management, LP (3.2%). In their latest 13Fs, 0 managers opened a new position and 5 added to one.
Has Congress traded HTFL?
No member of Congress has disclosed a trade in HTFL.
Who is the largest holder of HTFL?
Among 13F filers, Bain Capital Life Sciences Investors, LLC reports the largest HTFL position, $247.9M (8,448,158 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Bain Capital Life Sciences Investors, LLC's: 14.7% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.